We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

Peritoneal Ropivacaine Infiltration on Postoperative Pain in Children Affected

This study has been completed.
ClinicalTrials.gov Identifier:
First Posted: November 28, 2013
Last Update Posted: March 26, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Ping Yang, Tongji Hospital
The aim of this study was to evaluate the analgesic effect of intraperitoneal infiltration of ropivacaine in children undergoing laparoscopic surgery.

Condition Intervention Phase
Testicular Colic Drug: intraperitoneal infiltration of ropivacaine Phase 2

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Double (Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Evaluate the Analgesic Effect of Intraperitoneal Infiltration of Ropivacaine in Children Undergoing Laparoscopic Surgery

Resource links provided by NLM:

Further study details as provided by Ping Yang, Tongji Hospital:

Primary Outcome Measures:
  • pain score [ Time Frame: within the first 2days after the surgery ]

Secondary Outcome Measures:
  • Analgesic dose [ Time Frame: Within the first 2days after the surgery ]
  • Gastrointestinal function recovery score [ Time Frame: Within the first 2days after the surgery ]
  • Wound score [ Time Frame: Within the first 2days after the surgery ]
  • Time to discharge [ Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 2weeks ]

Enrollment: 70
Study Start Date: November 2013
Study Completion Date: June 2014
Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: ropivacaine
Preincisional wound intraperitoneal infiltration of 1% ropivacaine 0.3ml/kg was performed in group I patients before surgery.
Drug: intraperitoneal infiltration of ropivacaine
intraperitoneal infiltration of ropivacaine by a special equipment

Detailed Description:
  1. Quality assurance plan that addresses data validation and registry procedures, including any plans for site monitoring and auditing.
  2. Data checks to compare data entered into the registry against predefined rules for range or consistency with other data fields in the registry.
  3. Source data verification to assess the accuracy, completeness, or representativeness of registry data by comparing the data to external data sources .
  4. Data dictionary that contains detailed descriptions of each variable used by the registry, including the source of the variable, coding information .
  5. Standard Operating Procedures to address registry operations and analysis activities, such as patient recruitment, data collection, data management, data analysis, reporting for adverse events, and change management.
  6. Sample size assessment to specify the number of participants or participant years necessary to demonstrate an effect.
  7. Plan for missing data to address situations where variables are reported as missing, unavailable, "non-reported," uninterpretable, or considered missing because of data inconsistency or out-of-range results
  8. Statistical analysis plan describing the analytical principles and statistical techniques to be employed in order to address the primary and secondary objectives, as specified in the study protocol or plan

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   6 Months to 5 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  1. Between 6 months and 5years.
  2. Laparoscopic inguinal hernia repair
  3. Laparoscopic testicular descent fixation

Exclusion Criteria:

  1. Patient who are suffering from mental disease
  2. Patient who suffering from neuromuscular disease
  3. Local anesthetic allergy
  4. Patient who needs directly into ICU after the operation.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01997593

China, Hubei
Tongji Hospital
Wuhan, Hubei, China, 430030
Sponsors and Collaborators
Ping Yang
Study Director: Yang Hui, Professor China Tongji Hospital
  More Information

Responsible Party: Ping Yang, Principal Investigator, Tongji Hospital
ClinicalTrials.gov Identifier: NCT01997593     History of Changes
Other Study ID Numbers: 20130801
First Submitted: October 27, 2013
First Posted: November 28, 2013
Last Update Posted: March 26, 2015
Last Verified: March 2015

Keywords provided by Ping Yang, Tongji Hospital:

Additional relevant MeSH terms:
Anesthetics, Local
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents